New radiation therapy shows promise for liver metastases in early trial
NCT ID NCT05829291
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing a new type of radiation therapy called DaRT for people with liver tumors that have spread from colorectal cancer. The treatment involves placing tiny radioactive seeds directly into the tumors during surgery. The goal is to see if this approach is safe and feasible, and to measure how well it shrinks or destroys the tumors. Up to 10 participants will be enrolled.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER METASTASES are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
e McGill University Health Centre (MUHC)
RECRUITINGMontreal, Quebec, H4A 3T2, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A new test could reveal how radiation affects the liver
- A new clue in the fight against colorectal cancer recurrence?
- A new way to read CT scans may predict which liver surgery patients will develop Life-Threatening failure
- Could a two-vein embolization trick turn inoperable liver tumors into operable ones?
- Targeted chemotherapy pump takes fight directly to pancreatic cancer liver tumors
- Radiation and immunotherapy join forces against Hard-to-Treat liver metastases